Titre : | Druglink, Vol.29, n°4 - July-August 2014 - Future tense. What will the drivers for investment be going forward? |
Type de document : | Bulletin : Périodique |
Paru le : | 01/08/2014 |
Année de publication : | 2014 |
Format : | 30 p. |
Langues: | Anglais |
Note de contenu : |
CONTENTS:
NEWS: Are synthetic cannabinoids the new heroin? New York Times backs cannabis legalisation EU rule against medicines control of NPS Obituary: David Turner, 1949-2014 FEATURES: - The futures market: Marcus Roberts considers an analysis of the interplay between crime, heroin and poverty in the past - and what it may look like in the future. - Driven by loss: Three parents whose children died after taking drugs talk to Max Daly about how their grief has driven a desire to take action. - Crime-Busters or PCC Plods? According to former detective sergeant Geoff Monaghan, most Police and Crime Commissioners are not hitting the mark. - NICE of you to notice: Are users of image and performance-enhancing drugs finally getting the help they need? Joseph Kean and Jim McVeigh weigh up the evidence. - Scary monsters: Neil McKeganey asks if public health practitioners are starting a new moral panic over e-cigarettes. - TEN... and you're out: Unlicensed raves are popping up all over the UK. Peggy Whitfield examines why some promoters are choosing to go down the illegal route. - Joint ventures: Medical and recreational marijuana is now big business in North America. David Ader takes a look at the new economy of pot. - Drug and Alcohol Findings: What do the patients want? The Findings team analyse what policymakers mean by 'patient-centred care' and the implications for the drug and alcohol sector. REGULARS: Reviews Factsheet: Etizolam. |
Dépouillements
Ajouter le résultat dans votre panierArticle : Périodique
Etizolam is a benzodiazepine analogue. It has gathered some popularity on the new psychoactive substance (NPS) market in the UK and Europe. It has a broadly similar pharmacological profile to benzodiazepine drugs such as diazepam. A 1mg tablet i[...]
Exemplaires
Disponibilité |
---|
aucun exemplaire |
Accueil